1. Home
  2. TVTX vs LOMA Comparison

TVTX vs LOMA Comparison

Compare TVTX & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • LOMA
  • Stock Information
  • Founded
  • TVTX 2008
  • LOMA 1926
  • Country
  • TVTX United States
  • LOMA Argentina
  • Employees
  • TVTX N/A
  • LOMA N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • LOMA Building Materials
  • Sector
  • TVTX Health Care
  • LOMA Industrials
  • Exchange
  • TVTX Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • TVTX 1.5B
  • LOMA 1.3B
  • IPO Year
  • TVTX N/A
  • LOMA 2017
  • Fundamental
  • Price
  • TVTX $17.92
  • LOMA $10.18
  • Analyst Decision
  • TVTX Strong Buy
  • LOMA Strong Buy
  • Analyst Count
  • TVTX 16
  • LOMA 2
  • Target Price
  • TVTX $33.40
  • LOMA $15.00
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • LOMA 491.3K
  • Earning Date
  • TVTX 08-06-2025
  • LOMA 08-07-2025
  • Dividend Yield
  • TVTX N/A
  • LOMA N/A
  • EPS Growth
  • TVTX N/A
  • LOMA N/A
  • EPS
  • TVTX N/A
  • LOMA 0.37
  • Revenue
  • TVTX $333,865,000.00
  • LOMA $559,741,122.00
  • Revenue This Year
  • TVTX $71.61
  • LOMA $22.92
  • Revenue Next Year
  • TVTX $43.45
  • LOMA $25.84
  • P/E Ratio
  • TVTX N/A
  • LOMA $27.67
  • Revenue Growth
  • TVTX 87.94
  • LOMA N/A
  • 52 Week Low
  • TVTX $8.46
  • LOMA $6.76
  • 52 Week High
  • TVTX $25.29
  • LOMA $14.17
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.60
  • LOMA 36.10
  • Support Level
  • TVTX $17.24
  • LOMA $11.00
  • Resistance Level
  • TVTX $19.08
  • LOMA $10.87
  • Average True Range (ATR)
  • TVTX 0.87
  • LOMA 0.50
  • MACD
  • TVTX 0.04
  • LOMA -0.16
  • Stochastic Oscillator
  • TVTX 66.67
  • LOMA 4.37

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

Share on Social Networks: